Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Pancreatic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 3Uterine Cervical Neoplasms 2Nasopharyngeal Carcinoma 2Stomach Neoplasms 1Pancreatic Cancer Resectable 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Locally Advanced Gastric Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 2Carboplatin 2pembrolizumab 1iso-sulfan blue 1camrelizumab 1Watchful Waiting 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Positron Emission Tomography Computed Tomography 1Observation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1Chemoradiotherapy 1Cetuximab 1Capecitabine 1Biopsy 1Aminolevulinic Acid 1(225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Mouth Neoplasms × Taxes × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡